Intermittent Theta Burst Stimulation Attenuates Cognitive Deficits and Alzheimer's Disease-Type Pathologies via ISCA1-Mediated Mitochondrial Modulation in APP/PS1 Mice

Neurosci Bull. 2024 Feb;40(2):182-200. doi: 10.1007/s12264-023-01098-7. Epub 2023 Aug 14.

Abstract

Intermittent theta burst stimulation (iTBS), a time-saving and cost-effective repetitive transcranial magnetic stimulation regime, has been shown to improve cognition in patients with Alzheimer's disease (AD). However, the specific mechanism underlying iTBS-induced cognitive enhancement remains unknown. Previous studies suggested that mitochondrial functions are modulated by magnetic stimulation. Here, we showed that iTBS upregulates the expression of iron-sulfur cluster assembly 1 (ISCA1, an essential regulatory factor for mitochondrial respiration) in the brain of APP/PS1 mice. In vivo and in vitro studies revealed that iTBS modulates mitochondrial iron-sulfur cluster assembly to facilitate mitochondrial respiration and function, which is required for ISCA1. Moreover, iTBS rescues cognitive decline and attenuates AD-type pathologies in APP/PS1 mice. The present study uncovers a novel mechanism by which iTBS modulates mitochondrial respiration and function via ISCA1-mediated iron-sulfur cluster assembly to alleviate cognitive impairments and pathologies in AD. We provide the mechanistic target of iTBS that warrants its therapeutic potential for AD patients.

Keywords: Alzheimer’s disease; Intermittent theta burst stimulation; Iron-sulfur cluster assembly 1; Mitochondrial dysfunction; Neurodegeneration.

MeSH terms

  • Alzheimer Disease* / therapy
  • Animals
  • Cognition
  • Cognitive Dysfunction* / therapy
  • Humans
  • Iron
  • Iron-Sulfur Proteins*
  • Mice
  • Mitochondrial Proteins
  • Sulfur
  • Transcranial Magnetic Stimulation

Substances

  • Sulfur
  • Iron
  • ISCA1 protein, human
  • Iron-Sulfur Proteins
  • Mitochondrial Proteins